TITLE

Attribution of Hepatitis C Virus Seroconversion Risk in Young Injection Drug Users in 5 US Cities

AUTHOR(S)
Hagan, Holly; Pouget, Enrique R.; Williams, Ian T.; Garfein, Richard L.; Strathdee, Steffanie A.; Hudson, Sharon M.; Latka, Mary H.; Ouellet, Lawrence J.
PUB. DATE
February 2010
SOURCE
Journal of Infectious Diseases;2/1/2010, Vol. 201 Issue 3, p378
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. In studies of hepatitis C virus (HCV) seroconversion in injection drug users (IDUs), some have questioned whether underreporting of syringe sharing, a stigmatized behavior, has led to misattribution of HCV risk to other injection-related behaviors. Methods. IDUs aged 15-30 years who were seronegative for human immunodeficiency virus and HCV antibodies were recruited into a prospective study in 5 US cities. Behavioral data were collected via computer-assisted self-interviewing to reduce socially desirable reporting. Hazard ratios (HRs) were estimated to assess associations between behavior and HCV seroconversion. Because the shared use of cookers, cottons, and rinse water was highly correlated, a summary variable was created to represent drug preparation equipment sharing. Results. Among 483 IDUs who injected during the period covered by the follow-up assessments, the incidence of HCV infection was 17.2 cases per 100 person years; no HIV seroconversions occurred. Adjusting for confounders, the shared use of drug preparation equipment was significantly associated with HCV seroconversion (adjusted HR, 2.66; 95% confidence interval, 1.03-23.92), but syringe sharing was not (adjusted HR, 0.91). We estimated that 37% of HCV seroconversions in IDUs were due to the sharing of drug preparation equipment. Conclusions. Associations between sharing drug preparation equipment and HCV seroconversion are not attributable to underascertainment of syringe sharing. Avoiding HCV infection will require substantial reductions in exposure to all sources of contaminated blood.
ACCESSION #
47878043

 

Related Articles

  • Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S. White, Emily Faye; Garfein, Richard S.; Brouwer, Kimberly C.; Lozada, Remedios; Ramos, Rebeca; Firestone-Cruz, Michelle; Pérez, Saida G.; Magis-Rodríguez, Carlos; Conde-Glez, Carlos J.; Strathdee, Steffanie A. // Salud Pública de México;may/jun2007, Vol. 49 Issue 3, p165 

    Objective. To estimate the prevalence of the hepatitis C virus (HCV) and HIV infection and associated risk behaviors among injection drug users (IDUs) in two northern Mexican cities. Material and Methods. Between February and April 2005, IDUs were recruited in Tijuana (N=222) and Ciudad Juarez...

  • Neuropsychiatric Complications of Injection-Associated Diseases: HIV and Hepatitis C. Rado, Jeffrey // Psychiatric Annals;Jan2017, Vol. 47 Issue 1, p38 

    Intravenous use of illicit substances increases the risk for transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Both of these infections develop into chronic medical conditions with high morbidity and mortality. HIV and HCV may lead to significant neuropsychiatric...

  • HCV and HIV Counseling and Testing Integration in California: An Innovative Approach to Increase HIV Counseling and Testing Rates. Stopka, Thomas J.; Marshall, Clark; Bluthenthal, Ricky N.; Webb, David S.; Truax, Steven R. // Public Health Reports;May/Jun2007 Supplement, Vol. 122, p68 

    Objectives. In California, injection drug users (IDUs) comprise the second leading risk group for human immunodeficiency virus (HIV) infection and the majority of hepatitis C virus (HCV) cases. Innovative disease screening and prevention activities are needed to improve disease surveillance and...

  • Spread of Hepatitis C Virus among European Injection Drug Users Infected with HIV: A Phylogenetic Analysis. Van Asten, Liselotte; Verhaest, Inge; Lamzira, Saida; Hernandez-Aguado, IIdefonso; Zangerle, Robert; Boufassa, Faroudy; Rezza, Giovanni; Broers, Barbara; Robertson, J. Roy; Brettle, Raymond P.; McMenamin, Jim; Prins, Maria; Cochrane, Alexandra; Simmonds, Peter; Coutinho, Roel A.; Bruisten, Sylvia // Journal of Infectious Diseases;1/15/2004, Vol. 189 Issue 2, p292 

    To describe the spread of hepatitis C virus (HCV) among HCV/human immunodeficiency virus (HIV)-coinfected injection drug users (IDUs), the molecular epidemiology of HCV was studied among 108 IDUs from 7 European countries. Phylogenetic analysis based on the NS5B region showed great sequence...

  • Risk of hepatitis C infection among injection drug users in Mizoram, India. Chelleng, P. K.; Borkakoty, B. J.; Chetia, M.; Das, H. K.; Mahanta, J. // Indian Journal of Medical Research;Nov2008, Vol. 128 Issue 5, p640 

    Background & objectives: Prevalence of injection drug users (IDUs) is high in the northeastern region of India. This coupled with unsafe injecting practices as well as practice of tattooing in remote tribal areas call for baseline data on the prevalence of parentally transmitted viral diseases....

  • Harm reduction approach in Egypt: the insight of injecting drug users. Oraby, Doaa // Harm Reduction Journal;2013, Vol. 10 Issue 1, p1 

    Background: Egypt has low HIV prevalence (below 0.02%) among the general population, mostly attributed to the conservative culture. The 2010 second round biological/behavioral surveillance survey (Bio-BSS) conducted in some governorates revealed concentrated epidemic among male injecting drug...

  • High rate of seronegative HCV infection in HIV-positive patients. JUNIASTUTI; TAKAKO UTSUMI; NASRONUDIN; ALIMSARDJONO, LINDAWATI; AMIN, MOCHAMAD; ADIANTI, MYRNA; YOSHIHIKO YANO; SOETJIPTO; YOSHITAKE HAYASHI; HAK HOTTA; LUSIDA, MARIA INGE // Biomedical Reports;2014, Vol. 2 Issue 1, p79 

    Co-infection with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) is a significant global health problem. The two viruses are transmitted with high efficacy via blood-to-blood contact, mainly intravenous drug use (IVDU), whereas HCV is less easily transmitted sexually. Antibody...

  • Parvovirus 4 Infection and Clinical Outcome in High-Risk Populations. Simmons, Ruth; Sharp, Colin; McClure, C. Patrick; Rohrbach, Janine; Kovari, Helen; Frangou, Eleni; Simmonds, Peter; Irving, Will; Rauch, Andri; Bowness, Paul; Klenerman, Paul // Journal of Infectious Diseases;Jun2012, Vol. 205 Issue 12, p1816 

    Parvovirus 4 (PARV4) is a DNA virus frequently associated with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections, but its clinical significance is unknown. We studied the prevalence of PARV4 antibodies in 2 cohorts of HIV- and HCV-infected individuals (n = 469) and the...

  • Systematic review of HIV and HCV infection among drug users in China. Bao, Y.-P.; Liu, Z.-M. // International Journal of STD & AIDS;Jun2009, Vol. 20 Issue 6, p399 

    To determine the HIV and hepatitis C virus (HCV) geographical distribution among drug users in China, a systematic literature review of 40 peer-reviewed publications (comprising 15,565 drug users) was conducted. Of the total drug users, 10,724 were found to be injection drug users (IDUs) and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics